Robert C. Doebele

31.5k citations
250 papers · 10.4k · 5 hit papers · h-index 53

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
  • Oncology top 0.2%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Lung Cancer Treatments and Mutations 196
    • Lung Cancer Diagnosis and Treatment 18
    • Lung Cancer Research Studies 65
    • Colorectal Cancer Treatments and Studies 48
    • HER2/EGFR in Cancer Research 23

Robert C. Doebele

243 papers receiving 10.2k citations

Robert C. Doebele's Hit Papers

Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC 2019 · 356 citations
3560+4+9Years since publication250500750

Peers

Robert C. Doebele
Comparison fields: 5 of 109
  • Pulmonary and Respiratory Medicine 7.3k
  • Oncology 6.1k
  • Cancer Research 2.3k
  • Molecular Biology 4.0k
  • Pathology and Forensic Medicine 993
Replace Makoto Nishio with:
Makoto Nishio Japan
Natasha Rekhtman United States
Koji Tsuta Japan
Viktor Grünwald Germany
Isamu Okamoto Japan
Katerina Politi United States
Hidefumi Sasaki Japan
Rafał Dziadziuszko Poland
Frederic J. Kaye United States
Mark M. Awad United States
Robert C. Doebele relative to Makoto Nishio Japan Makoto Nishio's profile →
Citations per field
00.5×1.6×
Makoto Nishio · 1×
Citations per year

Countries citing papers authored by Robert C. Doebele

Since Specialization
Citations

This map shows the geographic impact of Robert C. Doebele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Doebele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Doebele more than expected).

Fields of papers citing papers by Robert C. Doebele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Doebele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Doebele. The network helps show where Robert C. Doebele may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert C. Doebele, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert C. Doebele Line = papers co-authored together Robert C. Doebele links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 250 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer
Hit paper breakdown →
2012820
2
Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
Hit paper breakdown →
2012508
3
TRKing Down an Old Oncogene in a New Era of Targeted Therapy
Hit paper breakdown →
2014464
4
Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC
Hit paper breakdown →
2019356
5 2012330
6
An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
Hit paper breakdown →
2015302
7 2013269
8 2010264
9 2012223
10 2014213
11 2011195
12 2012188
13 2018179
14 2013174
15 2014168
16 2018146
17 2018143
18 2018138
19 2016128
20 2016126

About Robert C. Doebele

Robert C. Doebele is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 250 papers that have together received 10.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (196 papers), Cancer Genomics and Diagnostics (65 papers), Lung Cancer Research Studies (65 papers), Colorectal Cancer Treatments and Studies (48 papers), HER2/EGFR in Cancer Research (23 papers), PI3K/AKT/mTOR signaling in cancer (19 papers), Cancer therapeutics and mechanisms (19 papers) and Lung Cancer Diagnosis and Treatment (18 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (7.3k citations), Oncology (6.1k citations), Cancer Research (2.3k citations), Molecular Biology (4.0k citations) and Pathology and Forensic Medicine (993 citations). Robert C. Doebele has collaborated with scholars based in United States, Italy and South Korea. Frequent co-authors include D. Ross Camidge, Dara L. Aisner, Marileila Varella‐Garcia, Anh T. Le, Andrew Weickhardt, Aria Vaishnavi, Kurtis D. Davies, Anh‐Tuan Le, Wilbur A. Franklin and Paul A. Bunn. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact